This inventor holds 1 USPTO granted patent. Top assignee: Ineos Healthcare Limited. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: The Innovations of Benjamin J Rankin
Introduction
Benjamin J Rankin is a notable inventor based in Hull, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of metal compounds for medical use. His innovative work focuses on addressing health issues such as hyperphosphataemia.
Latest Patents
Rankin holds a patent for "Metal compounds, mixed or sulphated, as phosphate binders." This mixed metal compound is free from aluminium and boasts a phosphate binding capacity of at least 30% by weight of the total phosphate present, across a pH range of 2-8. The compound is particularly beneficial for the treatment of hyperphosphataemia. The preferred metals used in this compound include iron (III) along with calcium, magnesium, lanthanum, and cerium. Additionally, a metal sulphate for pharmaceutical use is selected from calcium, lanthanum, and cerium sulphate compounds, also demonstrating a phosphate binding capacity of at least 30% by weight.
Career Highlights
Rankin is associated with Ineos Healthcare Limited, where he continues to innovate in the pharmaceutical sector. His work has the potential to improve treatment options for patients suffering from elevated phosphate levels.
Collaborations
Throughout his career, Rankin has collaborated with notable colleagues such as Norman Bryson Roberts and Maurice Webb. These partnerships have likely contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Benjamin J Rankin's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to improving healthcare solutions. His work in developing effective phosphate binders showcases the importance of innovation in addressing medical challenges.